36 results
DEFM14A
AMTI
Applied Molecular Transport Inc.
21 Nov 23
Proxy related to merger
9:16am
any assessment of its future success and viability subject to significant uncertainty.
AMTI will incur expenses and encounter difficulties … pending an impact assessment, or such manufacturing facilities may need to be closed for an extended period of time to investigate and remedy
425
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Business combination disclosure
5:12pm
. The Company’s management has completed an assessment of the effectiveness of the Company’s system of internal control over financial reporting in compliance … as set forth in the Company SEC Documents filed prior to the date of this Agreement, that assessment concluded that those controls were effective.
(e
8-K
EX-2.1
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
5:10pm
that could have a material effect on the financial statements. The Company’s management has completed an assessment of the effectiveness of the Company’s … , that assessment concluded that those controls were effective.
(e) The Company maintains, and at all times since June 5, 2020, has maintained disclosure
8-K
EX-99.1
4xyjfvsm
25 Apr 22
Applied Molecular Transport Announces Positive Top-line Phase 2 Results from FILLMORE
8:01am
8-K
EX-1.1
i360shz5t9t
28 Jan 22
Entry into a Material Definitive Agreement
12:00am
DEF 14A
3cwh vre2yz30g
7 Apr 21
Definitive proxy
4:05pm
424B4
6fme3
1 Apr 21
Prospectus supplement with pricing info
4:05pm